An in vivo study compared the survival of tumor-bearing CXCR3-deficient and wild-type mice in an orthotopic GBM model, and found that the mice in the CXCR3-deficient group showed reduced recruitment of NK and natural killer T (NKT) cells and poorer median survival time [25]. This evidence concerns the gene CXCR3 and glioblastoma.